Spirometric assessment of the rural population of Rejowiec Commune

Authors

  • Michał Sagan Department of Human Physiology, Medical University of Lublin Author
  • Joanna Warchulińska Department of Human Physiology, Medical University of Lublin Author
  • Mariola Dec-Szlichtyng Department of Human Physiology, Medical University of Lublin Author
  • Krystyna Lupa Department of Human Physiology, Medical University of Lublin Author
  • Monika Jakubiak Department of Human Physiology, Medical University of Lublin Author

Keywords:

spirometry, screening, overweight

Abstract

Introduction. Lung function tests are the oldest methods used to measure the air volume and capacities of the lungs. Such tests make it possible to diagnose respiratory disorders, localize them, assess their dynamics and reversibility, as well as set forth the conclusive prognoses. 

Aim. The aim of this study was to perform a screening spirometric examination among a chosen population with an indication for further diagnostic action and health education in the sphere of chronic diseases of the respiratory system. 

Material and method. The examinations covered a group of 273 adult inhabitants of Rejowiec Commune. The measurements were taken with the use of a portable MicroLab Spiro apparatus. The reference values in accordance with the American Thoracic Society (ATS) were used for the evaluation of the spirometric results. 

Results. The analysis of the mean values of individual spirometric parameters in relation to sex shows slightly higher values of FEV1, FVC, FEV1%FVC for women. For men, higher values were assessed for PEF%, MEF50%, and MEF25% (p<0.05). Statistically lower PEF, FEV1, MEF75%, and MEF50% values were observed in people under the age of 50 in comparison to people over this age limit. In 2.56% of the examined population, obstruction type impairments were observed (restriction type impairments - 8.06%). The results of the BMI calculation revealed I and II stage obesity in 84 people. The spirometric parameter values (FEV1, FVC, MEF50%, MEF25%) in this group were significantly lower (p<0.05) than in the group of people with proper body weight. Significantly lower mean values of spirometric parameters were observed in smokers, in comparison to non-smokers (FEV1, FEV1%FVC, PEF; p<0.05). 

Conclusions. Smoking tobacco, exposure to organic dust as well as overweight play an important role in the development of chronic respiratory diseases and are expressed in a decrease in spirometric values. 

References

1. Śliwiński P, Zieliński J. Rola badania spirometrycznego w rozpoznawaniu i leczeniu POCHP. Sł Zdr 2000;46-47:15-7.

2. Pierzchała W. Functional examinations of respiratory tract in asthma and obstructive pulmonary disease. Terapia 2002;3:12-8.

3. Topical review: guidelines for the measurement of respiratory function – recommendations of the British Thoracic Society and the Association of Respiratory Technicians and Physiologists. Respir Med 1994;88:165-94.

4. Barnes PJ. A new approach to the treatment of asthma. N Eng J Med 1989;321:1517-27.

5. Ingram RH Jr, Schilder DP. Effect of thoracic gas compression on the flow-volume curve of the forced vital capacity. Am Rev Respir Dis 1996;94:56-63.

6. Kerstjens AM. Huib, Rijcken B, Schouten JP, Postma DS. Decline of FEV1 by age and smoking status: facts, figures, and fallacies. Thorax 1997;52:820-7.

7. Pierzchała W. Functional examinations of respiratory tract in asthma and obstructive pulmonary disease. Terapia. 2002;3:12-8.

8. Pierzchała W. Wypadkowa maksymalnego przepływu i objętości (maxi-W. Wypadkowa maksymalnego przepływu i objętości (maxi- mum flow-volume loop) – test czynnościowy drobnych dróg oddecho- wych. Pneum Pol 1977;45:493-8.

9. Peat JK, Woolcock AJ, Cullen K. Rate of decline of lung function in subjects with asthma. Eur J Respir Dis 1987;70:171-9.

10. Tashkin DP, Altose MD, Connett JE. Metacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group. Am J Respir Crit Care Med 1996;153:1802-11.

11. American Thoracic Society: Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991;144:1202-8.

12. Doboszyńska A, Serafińska J. Spirometria w praktyce lekarskiej. Lekarz 2000;6:9-16.

13. Boros P, Martusewicz-Boros M, Doboszyńska A, Kowalski J, Droszcz W. Lung function tests in workers of the refinery in Plock (1993-frequency of COPD and FEV1 changes. Pneumonol Alergol Pol 1998;66(3-4):154-62.

14. Górecka D. Wskaźniki prognostyczne w przewlekłej obturacyjnej chorobie płuc. Przew Lek 2006;2(2):67-70.

15. National Center for Health Statistics: Current estimates from the National Health Interview Survey, United States, 1995. Washington, DC, Department of Health and Human Services, Public Health Service, Vital and Health Statistics, 1995. Publication No. 96-1527.

16. Dobosz K. Narażenie na bierne palenie papierosów a rezultat spirometrii u pacjentów bydgoskich przychodni rejonowych. Family Med Prim Care Rev 2006;8(3):585-7.

17. Zieliński J, Czajkowska-Malinowska M, Sankowski Z. Early detection of COPD by high risk population spirometric screening. Pneumonol Alergol Pol 2000;68:217-25.

18. Chinn D, Cotes J, Reed J. Longitudinal effects of change in body mass on measurements of ventilatory capacity. Thorax 1996;51,699-704.

19. Jones R, Nzekwu M. The effects of body mass index on lung volumes. Chest 2006;130:827-33.

20. Vergnenegre A, D’Arco X, Melloni B, Antonini MT, Courat C, Dupont- Cuisinier M, Bonnaud F. Work related distal airway obstruction in an agricultural population. Occup Envir Med 1995;52:581-6.

21. Zuskin E, Mustajbegovic J, Kern J, Sitar-Srebocan V. Respiratory function in poultry workers. Lijecnicki Vjesnik. 1995;117:121-5.

Downloads

Published

2010-12-01